List of Tables
Table 1. Global Choroidal Neovascularization Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Choroidal Neovascularization Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Choroidal Neovascularization Market Competitive Situation by Manufacturers in 2024
Table 4. Global Choroidal Neovascularization Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Choroidal Neovascularization Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Choroidal Neovascularization Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Choroidal Neovascularization Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Choroidal Neovascularization Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Choroidal Neovascularization, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Choroidal Neovascularization, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Choroidal Neovascularization, Product Type & Application
Table 12. Global Key Manufacturers of Choroidal Neovascularization, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Choroidal Neovascularization by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroidal Neovascularization as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Choroidal Neovascularization Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Choroidal Neovascularization Sales by Region (2020-2025) & (K Units)
Table 18. Global Choroidal Neovascularization Sales Market Share by Region (2020-2025)
Table 19. Global Choroidal Neovascularization Sales by Region (2026-2031) & (K Units)
Table 20. Global Choroidal Neovascularization Sales Market Share by Region (2026-2031)
Table 21. Global Choroidal Neovascularization Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Choroidal Neovascularization Revenue Market Share by Region (2020-2025)
Table 23. Global Choroidal Neovascularization Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Choroidal Neovascularization Revenue Market Share by Region (2026-2031)
Table 25. North America Choroidal Neovascularization Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Choroidal Neovascularization Sales by Country (2020-2025) & (K Units)
Table 27. North America Choroidal Neovascularization Sales by Country (2026-2031) & (K Units)
Table 28. North America Choroidal Neovascularization Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Choroidal Neovascularization Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Choroidal Neovascularization Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Choroidal Neovascularization Sales by Country (2020-2025) & (K Units)
Table 32. Europe Choroidal Neovascularization Sales by Country (2026-2031) & (K Units)
Table 33. Europe Choroidal Neovascularization Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Choroidal Neovascularization Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Choroidal Neovascularization Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Choroidal Neovascularization Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Choroidal Neovascularization Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Choroidal Neovascularization Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Choroidal Neovascularization Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Choroidal Neovascularization Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Choroidal Neovascularization Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Choroidal Neovascularization Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Choroidal Neovascularization Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Choroidal Neovascularization Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Choroidal Neovascularization Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Choroidal Neovascularization Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Choroidal Neovascularization Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Choroidal Neovascularization Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Choroidal Neovascularization Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Choroidal Neovascularization Sales (K Units) by Type (2020-2025)
Table 51. Global Choroidal Neovascularization Sales (K Units) by Type (2026-2031)
Table 52. Global Choroidal Neovascularization Sales Market Share by Type (2020-2025)
Table 53. Global Choroidal Neovascularization Sales Market Share by Type (2026-2031)
Table 54. Global Choroidal Neovascularization Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Choroidal Neovascularization Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Choroidal Neovascularization Revenue Market Share by Type (2020-2025)
Table 57. Global Choroidal Neovascularization Revenue Market Share by Type (2026-2031)
Table 58. Global Choroidal Neovascularization Price (USD/Unit) by Type (2020-2025)
Table 59. Global Choroidal Neovascularization Price (USD/Unit) by Type (2026-2031)
Table 60. Global Choroidal Neovascularization Sales (K Units) by Application (2020-2025)
Table 61. Global Choroidal Neovascularization Sales (K Units) by Application (2026-2031)
Table 62. Global Choroidal Neovascularization Sales Market Share by Application (2020-2025)
Table 63. Global Choroidal Neovascularization Sales Market Share by Application (2026-2031)
Table 64. Global Choroidal Neovascularization Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Choroidal Neovascularization Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Choroidal Neovascularization Revenue Market Share by Application (2020-2025)
Table 67. Global Choroidal Neovascularization Revenue Market Share by Application (2026-2031)
Table 68. Global Choroidal Neovascularization Price (USD/Unit) by Application (2020-2025)
Table 69. Global Choroidal Neovascularization Price (USD/Unit) by Application (2026-2031)
Table 70. Pfizer Inc. Company Information
Table 71. Pfizer Inc. Description and Business Overview
Table 72. Pfizer Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Inc. Choroidal Neovascularization Product
Table 74. Pfizer Inc. Recent Developments/Updates
Table 75. F. Hoffmann-La Roche Ltd. Company Information
Table 76. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 77. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product
Table 79. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 80. Novartis AG Company Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Novartis AG Choroidal Neovascularization Product
Table 84. Novartis AG Recent Developments/Updates
Table 85. Regeneron Pharmaceuticals Inc. Company Information
Table 86. Regeneron Pharmaceuticals Inc. Description and Business Overview
Table 87. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product
Table 89. Regeneron Pharmaceuticals Inc. Recent Developments/Updates
Table 90. Bayer AG Company Information
Table 91. Bayer AG Description and Business Overview
Table 92. Bayer AG Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Bayer AG Choroidal Neovascularization Product
Table 94. Bayer AG Recent Developments/Updates
Table 95. QLT Inc. Company Information
Table 96. QLT Inc. Description and Business Overview
Table 97. QLT Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. QLT Inc. Choroidal Neovascularization Product
Table 99. QLT Inc. Recent Developments/Updates
Table 100. Sanwa Kagaku Kenkyusho Co. Ltd. Company Information
Table 101. Sanwa Kagaku Kenkyusho Co. Ltd. Description and Business Overview
Table 102. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product
Table 104. Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates
Table 105. Promedior Inc. Company Information
Table 106. Promedior Inc. Description and Business Overview
Table 107. Promedior Inc. Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Promedior Inc. Choroidal Neovascularization Product
Table 109. Promedior Inc. Recent Developments/Updates
Table 110. Bausch Health Company Information
Table 111. Bausch Health Description and Business Overview
Table 112. Bausch Health Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Bausch Health Choroidal Neovascularization Product
Table 114. Bausch Health Recent Developments/Updates
Table 115. Gilead Sciences Inc Company Information
Table 116. Gilead Sciences Inc Description and Business Overview
Table 117. Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Gilead Sciences Inc Choroidal Neovascularization Product
Table 119. Gilead Sciences Inc Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Choroidal Neovascularization Distributors List
Table 123. Choroidal Neovascularization Customers List
Table 124. Choroidal Neovascularization Market Trends
Table 125. Choroidal Neovascularization Market Drivers
Table 126. Choroidal Neovascularization Market Challenges
Table 127. Choroidal Neovascularization Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Choroidal Neovascularization
Figure 2. Global Choroidal Neovascularization Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Choroidal Neovascularization Market Share by Type: 2024 & 2031
Figure 4. Intravenous Product Picture
Figure 5. Intravitreal Product Picture
Figure 6. Global Choroidal Neovascularization Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Choroidal Neovascularization Market Share by Application: 2024 & 2031
Figure 8. Extreme Myopia
Figure 9. Malignant Myopic Degeneration
Figure 10. Age-Related Developments
Figure 11. Global Choroidal Neovascularization Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Choroidal Neovascularization Market Size (2020-2031) & (US$ Million)
Figure 13. Global Choroidal Neovascularization Sales (2020-2031) & (K Units)
Figure 14. Global Choroidal Neovascularization Average Price (USD/Unit) & (2020-2031)
Figure 15. Choroidal Neovascularization Report Years Considered
Figure 16. Choroidal Neovascularization Sales Share by Manufacturers in 2024
Figure 17. Global Choroidal Neovascularization Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Choroidal Neovascularization Players: Market Share by Revenue in Choroidal Neovascularization in 2024
Figure 19. Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Choroidal Neovascularization Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Choroidal Neovascularization Sales Market Share by Country (2020-2031)
Figure 22. North America Choroidal Neovascularization Revenue Market Share by Country (2020-2031)
Figure 23. United States Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Mexico Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Choroidal Neovascularization Sales Market Share by Country (2020-2031)
Figure 27. Europe Choroidal Neovascularization Revenue Market Share by Country (2020-2031)
Figure 28. Germany Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. UK Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Choroidal Neovascularization Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Choroidal Neovascularization Revenue Market Share by Region (2020-2031)
Figure 35. China Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Vietnam Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Choroidal Neovascularization Sales Market Share by Country (2020-2031)
Figure 46. Latin America Choroidal Neovascularization Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Choroidal Neovascularization Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Choroidal Neovascularization Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Choroidal Neovascularization Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Choroidal Neovascularization by Type (2020-2031)
Figure 56. Global Revenue Market Share of Choroidal Neovascularization by Type (2020-2031)
Figure 57. Global Choroidal Neovascularization Price (USD/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Choroidal Neovascularization by Application (2020-2031)
Figure 59. Global Revenue Market Share of Choroidal Neovascularization by Application (2020-2031)
Figure 60. Global Choroidal Neovascularization Price (USD/Unit) by Application (2020-2031)
Figure 61. Choroidal Neovascularization Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
